Cost of treating type 1 diabetes and type 2 diabetes disproportionately falls on 10 states

A new report from the Institute for Alternative Futures shows that 10 states currently bear a disproportionate segment of the type 1 diabetes and type 2 diabetes burden in terms of costs, and predicts that the situation will only worsen in the coming years unless something is done to slow the spread of the disease.

The report, titled United States' Diabetes Crisis: Today and Future Trends, indicates that California, Texas, Florida, New York, Ohio, Illinois, Georgia, Pennsylvania, North Carolina and Michigan collectively pay 60 percent of the nation's diabetes costs.

Together, those states spent $176 billion on diabetes care in 2010, while the nation as a whole spent just under $300 billion. The cost to these states is expected to balloon to $297 billion in the next 15 years, according to the report.

"This research maps the alarming demographic realities of diabetes through 2025 if we don't make fundamental changes, particularly in our lifestyles and health system," said William Robert Rowley, a senior fellow at the institute who led the study. "The burden of diabetes will not fall equally. To change this tragic trajectory, it is imperative that public and private agencies work together on national, as well as state and local levels."

The findings are even more interesting in light of recent research from the Centers for Disease Control and Prevention on the prevalence of the disease. The study found that far more residents of southeastern states have diabetes. Yet, the new report shows that some northern and western states spend more. This may suggest that treatment costs are higher in some states or that many people simply aren't seeking care for their condition.